Alfresa Holdings Corporation (TYO:2784)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Unallocated Adjustment	-34.95B	-35.83B	-33.67B	-31.21B	-29.11B
Pharmaceutical Manufacturing Business	52.18B	54.07B	52.74B	49.04B	47.36B
Dispensing Pharmacy Business	37.17B	37.02B	36.65B	36.20B	34.47B
Self-Medication Wholesale Business	267.07B	265.75B	262.84B	246.68B	244.82B
Pharmaceutical Products Wholesale Segment	2.78T	2.64T	2.54T	2.40T	2.29T
Total	3.10T	2.96T	2.86T	2.70T	2.59T

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	3.10T	2.96T	2.86T	2.70T	2.59T
Total	3.10T	2.96T	2.86T	2.70T	2.59T

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error